Journal of Applied Physiology Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 88: 1737-1742, 2000;
8750-7587/00 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bairam, A.
Right arrow Articles by Marchal, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bairam, A.
Right arrow Articles by Marchal, F.
Vol. 88, Issue 5, 1737-1742, May 2000

Cholinergic dopamine release from the in vitro rabbit carotid body

Aida Bairam1, Habib Néji1, and François Marchal2

1 Unité de Recherche en Périnatologie, Centre Hospitalier Universitaire de Québec, Pavillon Saint François d'Assise, Université Laval, Quebec, Canada G1L 3L5; and 2 Laboratoire de Physiologie, Faculté de Médecine, UHP Nancy I, Vandoeuvre, France

The aim of this study was to test whether cholinergic mechanisms regulate dopamine (DA) release from the carotid body (CB) and interact with DA D2 autoreceptors. One hundred forty-two CBs from adult rabbits were infused in vitro in a surviving medium bubbled with O2 (Bairam A, Marchal F, Cottet-Emard JM, Basson H, Pequignot JM, Hascoet JM, and Lahiri S. J Appl Physiol 80: 20-24, 1996). CB DA content and release were measured after 1 h of exposure to various treatments: control, cholinergic agonist (0.1-50 µM carbachol), full muscarinic antagonist (1 and 10 µM atropine), antagonists of M1 and M2 muscarinic receptors (1 and 10 µM pirenzepine and 10 µM AFDX-116, respectively), and the DA D2 receptor antagonist domperidone (1 µM), alone and with carbachol (1 µM). Compared with control, the release of DA was significantly increased by carbachol (1-50 µM), AFDX-116, and domperidone and decreased by atropine (10 µM) and pirenzepine (10 µM). The effects of domperidone and carbachol were not significantly different but were clearly additive. It is concluded that, in the rabbit CB, M1 and M2 muscarinic receptor subtypes may be involved in the control of DA release, in addition to the DA D2 autoreceptors.

dopamine D2 autoreceptors; muscarinic receptor agonists and antagonists; domperidone


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
D.-K. Kim, N. Natarajan, N. R. Prabhakar, and G. K. Kumar
Facilitation of dopamine and acetylcholine release by intermittent hypoxia in PC12 cells: involvement of calcium and reactive oxygen species
J Appl Physiol, March 1, 2004; 96(3): 1206 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D.-K. Kim, N. R. Prabhakar, and G. K. Kumar
Acetylcholine release from the carotid body by hypoxia: evidence for the involvement of autoinhibitory receptors
J Appl Physiol, January 1, 2004; 96(1): 376 - 383.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online